Cargando…
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4
Autores principales: | Malik, A., Bromage, D. I., He, Z., Candilio, L., Hamarneh, A., Taferner, S., Davidson, S. M., Yellon, D. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674527/ https://www.ncbi.nlm.nih.gov/pubmed/26482377 http://dx.doi.org/10.1007/s10557-015-6622-5 |
Ejemplares similares
-
Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy
por: Ziff, Oliver J, et al.
Publicado: (2018) -
Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium()
por: Bromage, Daniel I., et al.
Publicado: (2014) -
Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury
por: Bromage, Daniel I., et al.
Publicado: (2019) -
A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies
por: Bromage, Daniel I., et al.
Publicado: (2017) -
CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α
por: Esencay, Mine, et al.
Publicado: (2013)